Metabolic selection of glycosylation defects in human cells

Kevin J Yarema, Scarlett Goon, Carolyn R. Bertozzi

Research output: Contribution to journalArticle

Abstract

Changes in glycosylation are often associated with disease progression, but the genetic and metabolic basis of these events is rarely understood in detail at a molecular level. We describe a metabolism-based approach to the selection of mutants in glycoconjugate biosynthesis that provides insight into regulatory mechanisms for oligosaccharide expression and metabolic flux. Unnatural intermediates are used to challenge a specific pathway, and cell surface expression of their metabolic products provides a readout of flux in that pathway and a basis for selecting genetic mutants. The approach was applied to the sialic acid metabolic pathway in human cells, yielding novel mutants with phenotypes related to the inborn metabolic defect sialuria and metastatic tumor cells.

Original languageEnglish (US)
Pages (from-to)553-558
Number of pages6
JournalNature Biotechnology
Volume19
Issue number6
DOIs
StatePublished - 2001

Fingerprint

Glycosylation
Cells
Fluxes
Oligosaccharides
Defects
Glycoconjugates
Sialic Acid Storage Disease
Biosynthesis
N-Acetylneuraminic Acid
Metabolism
Tumors
Metabolic Networks and Pathways
Acids
Disease Progression
Phenotype
Neoplasms

ASJC Scopus subject areas

  • Microbiology

Cite this

Metabolic selection of glycosylation defects in human cells. / Yarema, Kevin J; Goon, Scarlett; Bertozzi, Carolyn R.

In: Nature Biotechnology, Vol. 19, No. 6, 2001, p. 553-558.

Research output: Contribution to journalArticle

Yarema, Kevin J ; Goon, Scarlett ; Bertozzi, Carolyn R. / Metabolic selection of glycosylation defects in human cells. In: Nature Biotechnology. 2001 ; Vol. 19, No. 6. pp. 553-558.
@article{8746a13c17234ddabcc73803e254c8ff,
title = "Metabolic selection of glycosylation defects in human cells",
abstract = "Changes in glycosylation are often associated with disease progression, but the genetic and metabolic basis of these events is rarely understood in detail at a molecular level. We describe a metabolism-based approach to the selection of mutants in glycoconjugate biosynthesis that provides insight into regulatory mechanisms for oligosaccharide expression and metabolic flux. Unnatural intermediates are used to challenge a specific pathway, and cell surface expression of their metabolic products provides a readout of flux in that pathway and a basis for selecting genetic mutants. The approach was applied to the sialic acid metabolic pathway in human cells, yielding novel mutants with phenotypes related to the inborn metabolic defect sialuria and metastatic tumor cells.",
author = "Yarema, {Kevin J} and Scarlett Goon and Bertozzi, {Carolyn R.}",
year = "2001",
doi = "10.1038/89305",
language = "English (US)",
volume = "19",
pages = "553--558",
journal = "Biotechnology",
issn = "1087-0156",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Metabolic selection of glycosylation defects in human cells

AU - Yarema, Kevin J

AU - Goon, Scarlett

AU - Bertozzi, Carolyn R.

PY - 2001

Y1 - 2001

N2 - Changes in glycosylation are often associated with disease progression, but the genetic and metabolic basis of these events is rarely understood in detail at a molecular level. We describe a metabolism-based approach to the selection of mutants in glycoconjugate biosynthesis that provides insight into regulatory mechanisms for oligosaccharide expression and metabolic flux. Unnatural intermediates are used to challenge a specific pathway, and cell surface expression of their metabolic products provides a readout of flux in that pathway and a basis for selecting genetic mutants. The approach was applied to the sialic acid metabolic pathway in human cells, yielding novel mutants with phenotypes related to the inborn metabolic defect sialuria and metastatic tumor cells.

AB - Changes in glycosylation are often associated with disease progression, but the genetic and metabolic basis of these events is rarely understood in detail at a molecular level. We describe a metabolism-based approach to the selection of mutants in glycoconjugate biosynthesis that provides insight into regulatory mechanisms for oligosaccharide expression and metabolic flux. Unnatural intermediates are used to challenge a specific pathway, and cell surface expression of their metabolic products provides a readout of flux in that pathway and a basis for selecting genetic mutants. The approach was applied to the sialic acid metabolic pathway in human cells, yielding novel mutants with phenotypes related to the inborn metabolic defect sialuria and metastatic tumor cells.

UR - http://www.scopus.com/inward/record.url?scp=0035006049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035006049&partnerID=8YFLogxK

U2 - 10.1038/89305

DO - 10.1038/89305

M3 - Article

VL - 19

SP - 553

EP - 558

JO - Biotechnology

JF - Biotechnology

SN - 1087-0156

IS - 6

ER -